We selected 63 prostate tumors with Gleason's grade 6 (3+3), commonly showing both tubular and cribrous patterns. We compared in both patterns the expression of two of the most used biologic markers: PCNA and p53, with the aim to verify the validity of the Gleason's grading system to compare the morphologic grade with biologic aggressiveness and prognostic value. We did not find any statistical difference in the protein immunopositivity, indicating that both patterns could have identical biologic behaviour; then we confirmed the validity of Gleason's system for considering both tubular and cribrous patterns as an intermediate grade of tumoral differentiation. Moreover, we found a linear relationship between the increase of PCNA and the accu...
The prognosis in prostate cancer depends on several clinical-morphological factors, such as Gleason ...
Background: The study of the expression of different biological markers in non-neoplastic, pre-neopl...
Objective: To characterize p53 and PCNA expression in primary tumors and lymph nodes metastases of o...
We selected 63 prostate tumors with Gleason's grade 6 (3+3), commonly showing both tubular and cribr...
The surgical specimens from 51 men submitted to radical prostatectomy for localized prostate cancer ...
Background & Objectives: Prostate cancer is the most common malignant tumour of the male reproductiv...
This review addresses the significance of the expression of proliferating cell nuclear antigen (PCNA...
<p><strong>Background.</strong> Prostate cancer (PC) is one of the most common malignant tumors in m...
Mutation of the p53 gene is the most common genetic alteration in human cancers. The mutant p53 prot...
The immunohistochemical expression of proliferating cell nuclear antigen (PCNA) and p53 was investig...
Abstract Background: The early detection of prostate cancer has resulted in an increase in the numbe...
The 2021 novelties in prognostic and therapeutic tissue markers in patients with prostate cancer (PC...
The 2021 novelties in prognostic and therapeutic tissue markers in patients with prostate cancer (PC...
Antibodies to assess the proliferative index of tumours are being increasingly employed together wit...
Objectives: Prostate cancer (PCa) and Benign Prostatic Hyperplasia (BPH) are the leading cause of ur...
The prognosis in prostate cancer depends on several clinical-morphological factors, such as Gleason ...
Background: The study of the expression of different biological markers in non-neoplastic, pre-neopl...
Objective: To characterize p53 and PCNA expression in primary tumors and lymph nodes metastases of o...
We selected 63 prostate tumors with Gleason's grade 6 (3+3), commonly showing both tubular and cribr...
The surgical specimens from 51 men submitted to radical prostatectomy for localized prostate cancer ...
Background & Objectives: Prostate cancer is the most common malignant tumour of the male reproductiv...
This review addresses the significance of the expression of proliferating cell nuclear antigen (PCNA...
<p><strong>Background.</strong> Prostate cancer (PC) is one of the most common malignant tumors in m...
Mutation of the p53 gene is the most common genetic alteration in human cancers. The mutant p53 prot...
The immunohistochemical expression of proliferating cell nuclear antigen (PCNA) and p53 was investig...
Abstract Background: The early detection of prostate cancer has resulted in an increase in the numbe...
The 2021 novelties in prognostic and therapeutic tissue markers in patients with prostate cancer (PC...
The 2021 novelties in prognostic and therapeutic tissue markers in patients with prostate cancer (PC...
Antibodies to assess the proliferative index of tumours are being increasingly employed together wit...
Objectives: Prostate cancer (PCa) and Benign Prostatic Hyperplasia (BPH) are the leading cause of ur...
The prognosis in prostate cancer depends on several clinical-morphological factors, such as Gleason ...
Background: The study of the expression of different biological markers in non-neoplastic, pre-neopl...
Objective: To characterize p53 and PCNA expression in primary tumors and lymph nodes metastases of o...